Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 2
2012 4
2013 10
2014 7
2015 4
2016 3
2017 6
2018 10
2019 11
2020 5
2021 16
2022 12
2023 13
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: dukart j. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study.
Premi E, Pengo M, Mattioli I, Cantoni V, Dukart J, Gasparotti R, Buratti E, Padovani A, Bocchetta M, Todd EG, Bouzigues A, Cash DM, Convery RS, Russell LL, Foster P, Thomas DL, van Swieten JC, Jiskoot LC, Seelaar H, Galimberti D, Sanchez-Valle R, Laforce R Jr, Moreno F, Synofzik M, Graff C, Masellis M, Tartaglia MC, Rowe JB, Tsvetanov KA, Vandenberghe R, Finger E, Tiraboschi P, de Mendonça A, Santana I, Butler CR, Ducharme S, Gerhard A, Levin J, Otto M, Sorbi S, Le Ber I, Pasquier F, Rohrer JD, Borroni B; Genetic Frontotemporal dementia Initiative (GENFI). Premi E, et al. Among authors: dukart j. Neurobiol Dis. 2023 Apr;179:106068. doi: 10.1016/j.nbd.2023.106068. Epub 2023 Mar 8. Neurobiol Dis. 2023. PMID: 36898614 Free article.
Social brain, social dysfunction and social withdrawal.
Porcelli S, Van Der Wee N, van der Werff S, Aghajani M, Glennon JC, van Heukelum S, Mogavero F, Lobo A, Olivera FJ, Lobo E, Posadas M, Dukart J, Kozak R, Arce E, Ikram A, Vorstman J, Bilderbeck A, Saris I, Kas MJ, Serretti A. Porcelli S, et al. Among authors: dukart j. Neurosci Biobehav Rev. 2019 Feb;97:10-33. doi: 10.1016/j.neubiorev.2018.09.012. Epub 2018 Sep 20. Neurosci Biobehav Rev. 2019. PMID: 30244163 Free article. Review.
Naturalizing psychopathology-towards a quantitative real-world psychiatry.
Lahnakoski JM, Eickhoff SB, Dukart J, Schilbach L. Lahnakoski JM, et al. Among authors: dukart j. Mol Psychiatry. 2022 Feb;27(2):781-783. doi: 10.1038/s41380-021-01322-8. Epub 2021 Oct 20. Mol Psychiatry. 2022. PMID: 34667260 Free PMC article. No abstract available.
Social interaction, psychotic disorders and inflammation: A triangle of interest.
Faustmann TJ, Kamp D, Räuber S, Dukart J, Melzer N, Schilbach L. Faustmann TJ, et al. Among authors: dukart j. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Mar 2;122:110697. doi: 10.1016/j.pnpbp.2022.110697. Epub 2022 Dec 12. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36521587 Review.
Changes in patterns of age-related network connectivity are associated with risk for schizophrenia.
Passiatore R, Antonucci LA, DeRamus TP, Fazio L, Stolfa G, Sportelli L, Kikidis GC, Blasi G, Chen Q, Dukart J, Goldman AL, Mattay VS, Popolizio T, Rampino A, Sambataro F, Selvaggi P, Ulrich W; Apulian Network on Risk for Psychosis; Weinberger DR, Bertolino A, Calhoun VD, Pergola G. Passiatore R, et al. Among authors: dukart j. Proc Natl Acad Sci U S A. 2023 Aug 8;120(32):e2221533120. doi: 10.1073/pnas.2221533120. Epub 2023 Aug 1. Proc Natl Acad Sci U S A. 2023. PMID: 37527347 Free PMC article.
Functional connectivity signatures of NMDAR dysfunction in schizophrenia-integrating findings from imaging genetics and pharmaco-fMRI.
Gaebler AJ, Fakour N, Stöhr F, Zweerings J, Taebi A, Suslova M, Dukart J, Hipp JF, Adhikari BM, Kochunov P, Muthukumaraswamy SD, Forsyth A, Eggermann T, Kraft F, Kurth I, Paulzen M, Gründer G, Schneider F, Mathiak K. Gaebler AJ, et al. Among authors: dukart j. Transl Psychiatry. 2023 Feb 16;13(1):59. doi: 10.1038/s41398-023-02344-2. Transl Psychiatry. 2023. PMID: 36797233 Free PMC article. Clinical Trial.
Unravelling neurotransmitters impairment in primary progressive aphasias.
Premi E, Dukart J, Mattioli I, Libri I, Pengo M, Gadola Y, Cotelli M, Manenti R, Binetti G, Gazzina S, Alberici A, Magoni M, Koch G, Gasparotti R, Padovani A, Borroni B. Premi E, et al. Among authors: dukart j. Hum Brain Mapp. 2023 Apr 15;44(6):2245-2253. doi: 10.1002/hbm.26206. Epub 2023 Jan 17. Hum Brain Mapp. 2023. PMID: 36649260 Free PMC article.
90 results